Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis

被引:185
作者
Feitelson, Mark A.
Lee, Jungmin
机构
[1] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA
关键词
hepatitis B virus; hepatocellular carcinoma; hepatitis B x antigen; genetic changes; oncogenes; tumor suppressor genes; microRNAs; loss of heterozygosity; hepatocarcniogenesis; fragile sites; genetic instability; tumor suppressors;
D O I
10.1016/j.canlet.2006.11.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chronic liver disease associated with long term hepatitis B virus (HBV) infection contributes importantly to the development of hepatocellular carcinoma (HCC). A salient feature of these chronic infections is the integration of subgenomic HBV DNA fragments into many different locations within the host DNA, suggesting that integration is random. Although this may promote genetic instability during liver regeneration which accompanies a bout of chronic liver disease, the actual role of integrated HBV DNA in hepatocarcinogenesis is uncertain. Importantly, most integration events retain the HBV open reading frame encoding the HBx antigen (HBxAg), which is the virus contribution to HCC. In addition, many integration events reported in the literature occur near or within fragile sites or other cancer associated regions of the human genome that are prone to instability in tumor development and progression. Genetic instability associated with integration potentially alters the expression of oncogenes, tumor suppressor genes, and rnicroRNAs (miRNAs) that may contribute importantly to tumorigenesis. If so, then selected integration events may alter pathways that are rate limiting in hepatocarcinogenesis, thereby providing targets with diagnostic/prognostic potential and for therapeutic intervention. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:157 / 170
页数:14
相关论文
共 126 条
[81]   Multiple chromosomal abnormalities in human liver (pre)neoplasia [J].
Raidl, M ;
Pirker, C ;
Schulte-Hermann, R ;
Aubele, M ;
Kandioler-Eckersberger, D ;
Wrba, F ;
Micksche, M ;
Berger, W ;
Grasl-Kraupp, B .
JOURNAL OF HEPATOLOGY, 2004, 40 (04) :660-668
[82]   Genetic alterations in hepatocellular carcinomas:: association between loss of chromosome 4q and p53 gene mutations [J].
Rashid, A ;
Wang, JS ;
Qian, GS ;
Lu, BX ;
Hamilton, SR ;
Groopman, JD .
BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) :59-66
[83]   PREFERENTIAL INTEGRATION OF MARKER DNA INTO THE CHROMOSOMAL FRAGILE SITE AT 3P14 - AN APPROACH TO CLONING FRAGILE SITES [J].
RASSOOL, FV ;
MCKEITHAN, TW ;
NEILLY, ME ;
VANMELLE, E ;
ESPINOSA, R ;
LEBEAU, MM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) :6657-6661
[84]   HEPADNAVIRUSES IN CIRRHOTIC LIVER AND HEPATOCELLULAR-CARCINOMA [J].
ROBINSON, WS ;
KLOTE, L ;
AOKI, N .
JOURNAL OF MEDICAL VIROLOGY, 1990, 31 (01) :18-32
[85]   Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: possible association with an inherited disease and cancer [J].
Rozier, L ;
El-Achkar, E ;
Apiou, F ;
Debatisse, M .
ONCOGENE, 2004, 23 (41) :6872-6880
[86]   HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer [J].
Shamay, M ;
Agami, R ;
Shaul, Y .
ONCOGENE, 2001, 20 (47) :6811-6819
[87]   Hepatitis B virus X protein inhibits transforming growth factor-β-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway [J].
Shih, WL ;
Kuo, ML ;
Chuang, SE ;
Cheng, AL ;
Doong, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25858-25864
[88]   INTEGRATION OF HEPATITIS-B VIRUS AND ALTERATION OF THE 1P36 REGION FOUND IN CANCEROUS-TISSUE OF PRIMARY HEPATOCELLULAR-CARCINOMA WITH VIRAL REPLICATION EVIDENCED ONLY IN NONCANCEROUS, CIRRHOTIC TISSUE [J].
SIMON, D ;
CARR, BI .
HEPATOLOGY, 1995, 22 (05) :1393-1398
[89]  
Sirma H, 1999, FALK SYMP, V103C, P171
[90]   REPLICATION OF THE GENOME OF A HEPATITIS-B-LIKE VIRUS BY REVERSE TRANSCRIPTION OF AN RNA INTERMEDIATE [J].
SUMMERS, J ;
MASON, WS .
CELL, 1982, 29 (02) :403-415